Temodal and platelet count decreased 
Temodal and platelet count decreased Patient Reports February 12, 2012
Temodal Side Effects Report #6008366-6
Temodal side effect was reported by a Physician from JAPAN on Dec 08, 2008. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, condition aggravated, disease progression, disseminated intravascular coagulation, platelet count decreased, pneumonia
, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2;QD;PO; 200 MG/M2;QD;PO; 200 MG/M2;QD;PO. During the same period patient was treated with COTRIM, ZOFRAN, PRIMPERAN, LENDORMIN D, EXCEGRAN. Patient died on 03/06/2007.Temodal Side Effects Report #5975409-5
Temodal side effect was reported by a Physician from JAPAN on Nov 25, 2008. Male patient, 47 years of age, weighting 156.5 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, non-hodgkin's lymphoma, oligodendroglioma, platelet count decreased, precursor b-lymphoblastic lymphoma. Temodal dosage: unknown. Patient was hospitalized. Patient died on 07/05/2008.
Temodal Side Effects Report #5258242-1
Temodal side effect was reported by a Health Professional from CANADA on Feb 20, 2007. Female patient, 38 years of age, weighting 163.0 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: cough, diabetes insipidus
, disease progression, haemoglobin decreased, hypothyroidism, nausea , platelet count decreased, rhinorrhoea, sciatica . Temodal dosage: unknown. During the same period patient was treated with DECADRON, KYTRIL. Patient recovered.Temodal Side Effects Report #5408383-0
Temodal side effect was reported by a Physician from JAPAN on July 30, 2007. Male patient, 20 years of age, weighting 114.6 lb, was diagnosed with oligodendroglioma, disease recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, metastases to liver, metastases to lung, metastases to skin, platelet count decreased. Temodal dosage: PO, 150 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, NASEA, BROCIN CODEINE, DECADRON, FAMOTIDINE, MAGMITT, PREDONINE. Patient died on 02/04/2007.
Temodal Side Effects Report #5354597-8
Temodal side effect was reported by a Physician from JAPAN on May 24, 2007. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with neoplasm recurrence, oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, platelet count decreased, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with BAKTAR. Patient died on 03/06/2007.
Temodal Side Effects Report #4844923-8
Temodal side effect was reported by a Physician from NORWAY on Nov 17, 2005. Female patient, 65 years of age, was diagnosed with neoplasm malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, white blood cell count decreased. Temodal dosage: 120 MG ORAL. Patient died.
Temodal Side Effects Report #5935242-7
Temodal side effect was reported by a Physician from GREECE on Oct 17, 2008. Male patient, 55 years of age, was diagnosed with multiple myeloma
and was treated with Temodal. After drug was administered, patient experienced the following side effects: infection , leukopenia, platelet count decreased. Temodal dosage: 75 MG/M2; PO. Patient recovered.Temodal Side Effects Report #4852951-1
Temodal side effect was reported by a Physician from NORWAY on Dec 01, 2005. Female patient, 65 years of age, was diagnosed with mixed oligo-astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: fall
, haemoglobin decreased, head injury, intracranial tumour haemorrhage, platelet count decreased, unevaluable event, white blood cell count decreased. Temodal dosage: 140 MG QD ORAL. During the same period patient was treated with WARFARIN, MEDROL, NEXIUM, TRIMONIL. Patient died on 10/21/2005.Temodal Side Effects Report #5548332-8
Temodal side effect was reported by a Physician from JAPAN on Dec 03, 2007. Male patient, 63 years of age, weighting 156.5 lb, was diagnosed with malignant oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: convulsion, disease progression, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2; QD; PO150 MG/M2; QD; PO. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient died on 11/27/2007.
Temodal Side Effects Report #5768663-6
Temodal side effect was reported by a Physician from UNITED KINGDOM on June 06, 2008. Female patient, 30 years of age, was diagnosed with malignant melanoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased. Temodal dosage: unknown. Patient died.
Temodal Side Effects Report #5789381-4
Temodal side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 18, 2008. Female patient, 30 years of age, was diagnosed with malignant melanoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased. Temodal dosage: unknown. Patient died.
Temodal Side Effects Report #5270185-6
Temodal side effect was reported by a Physician from FRANCE on Mar 01, 2007. Female patient, child 10 years of age, was diagnosed with malignant glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: catheter sepsis, febrile bone marrow aplasia, haemoglobin decreased, platelet count decreased, staphylococcal sepsis. Temodal dosage: 200 MG; QD; PO. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5278068-2
Temodal side effect was reported by a Physician from FRANCE on Mar 15, 2007. Female patient, child 10 years of age, was diagnosed with malignant glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: device related infection, febrile bone marrow aplasia, haemoglobin decreased, platelet count decreased, staphylococcal sepsis. Temodal dosage: 200 MG; QD; PO. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5784859-1
Temodal side effect was reported by a Physician from FRANCE on June 17, 2008. Female patient, 69 years of age, weighting 123.5 lb, was diagnosed with lymphoma
and was treated with Temodal. After drug was administered, patient experienced the following side effects: dyspnoea, hyperthermia, intestinal infarction, platelet count decreased. Temodal dosage: 230 MG; QD; PO. During the same period patient was treated with METHOTREXATE, MEDROL, LOVENOX, CACIT D, NEXIUM. Patient was hospitalized. Patient died on 06/09/2008.Temodal Side Effects Report #5309223-0
Temodal side effect was reported by a Physician from JAPAN on Apr 13, 2007. Male patient, 80 years of age, weighting 85.98 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, guttate psoriasis, platelet count decreased, pneumonia
. Temodal dosage: unknown. During the same period patient was treated with PREDONINE, BASEN, STARSIS, PARULEON, MAGNESIUM OXIDE, DEPAS. Patient recovered.Temodal Side Effects Report #5451914-5
Temodal side effect was reported by a Physician from JAPAN on Sept 06, 2007. Male patient, 80 years of age, weighting 85.98 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: acarodermatitis, disseminated intravascular coagulation, guttate psoriasis, neutrophil count increased, platelet count decreased, pneumonia aspiration, renal impairment, urinary retention. Temodal dosage: unknown. During the same period patient was treated with PREDONINE, BASEN, STARSIS, PARULEON, MAGNESIUM OXIDE, DEPAS. Patient recovered.
Temodal Side Effects Report #5663867-5
Temodal side effect was reported by a Physician from JAPAN on Mar 05, 2008. Male patient, 80 years of age, weighting 85.98 lb, was diagnosed with glioblastoma multiforme, hypertension and was treated with Temodal. After drug was administered, patient experienced the following side effects: aspiration, disseminated intravascular coagulation, gastric ulcer, guttate psoriasis, hepatic function abnormal, neutrophil count increased, platelet count decreased, pneumonia
, urinary retention. Temodal dosage: 150 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO. During the same period patient was treated with BASEN, NATEGLINIDE, PREDNISONE, PARULEON, MAGNESIUM OXIDE, DEPAS. Patient recovered.Temodal Side Effects Report #5236365-0
Temodal side effect was reported by a Physician from JAPAN on Feb 05, 2007. Male patient, 77 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: infection
, platelet count decreased, white blood cell count decreased. Temodal dosage: 140 MG; QD; PO. During the same period patient was treated with FERON. Patient died on 01/30/2007.Temodal Side Effects Report #5248553-8
Temodal side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, 77 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, sepsis
, white blood cell count decreased. Temodal dosage: 140 MG;QD;PO. During the same period patient was treated with FERON. Patient died on 01/30/2007.Temodal Side Effects Report #5332848-3
Temodal side effect was reported by a Physician from JAPAN on May 17, 2007. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, sepsis
. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with FERON, MUCOSTA, GASTER, MEBALOTIN, AMLODIN, EXCEGRAN, GLYCYRON. Patient died on 01/30/2007.Temodal Side Effects Report #5483255-4
Temodal side effect was reported by a Physician from JAPAN on Oct 01, 2007. Male patient, 77 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood urea increased, c-reactive protein increased, platelet count decreased, red blood cell count decreased, sepsis
, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with FERON, MUCOSTA, FAMOTIDINE, PRAVASTATIN, AMLODIPINE, EXCEGRAN, GLYCYRON. Patient died on 01/30/2007.Temodal Side Effects Report #5212949-0
Temodal side effect was reported by a Physician from ISRAEL on Dec 18, 2006. Female patient, 73 years of age, weighting 129.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, infection
, neutrophil count decreased, platelet count decreased, pneumonia streptococcal, pulmonary oedema. Temodal dosage: 230 MG, QD; PO. During the same period patient was treated with DEXAMETHASONE, VALPROIC ACID. Patient was hospitalized. Patient died on 12/23/2006.Temodal Side Effects Report #5268846-8
Temodal side effect was reported by a Physician from ISRAEL on Feb 28, 2007. Female patient, 73 years of age, weighting 129.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bacteraemia, bronchopulmonary aspergillosis, fall
, neutropenia, pelvic fracture, platelet count decreased, pneumonia streptococcal, pulmonary oedema. Temodal dosage: 230 MG; QD; PO. During the same period patient was treated with DEXAMETHASONE, VALPROIC ACID. Patient was hospitalized. Patient died on 12/23/2006.Temodal Side Effects Report #5364309-X
Temodal side effect was reported by a Physician from JAPAN on June 11, 2007. Female patient, 73 years of age, weighting 88.18 lb, was diagnosed with glioblastoma multiforme, neoplasm recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia
. Temodal dosage: unknown. During the same period patient was treated with BAKTAR. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5723196-8
Temodal side effect was reported by a Physician from JAPAN on Apr 21, 2008. Female patient, 73 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, pneumonia
. Temodal dosage: 154 MG/M2;QD;PO, 210 MG/M2;QD;PO, 210 MG/M2;QD;PO, 210 MG/M2;QD;PO. During the same period patient was treated with BAKTAR, NASEA OD, NAUZELIN, MAGNESIUM OXIDE, CALBLOCK. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #6112253-2
Temodal side effect was reported by a Physician from JAPAN on Mar 06, 2009. Female patient, 73 years of age, weighting 88.18 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, lymphocyte count decreased, platelet count decreased, pneumonia
. Temodal dosage: 154 MG/M2/;QD;PO : 210 MG/M2;QD;PO : 210 MG/M2;QD;PO : 210 MG;M2;QD;PO. During the same period patient was treated with BAKTAR, NASEA OD, NAUZELIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 07/28/2008.Temodal Side Effects Report #4575931-2
Temodal side effect was reported by a Physician from on Jan 27, 2005. Male patient, 72 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, respiratory failure. Temodal dosage: 200MG/M2 QD ORAL. Patient died on 12/07/2004.
Temodal Side Effects Report #5616720-7
Temodal side effect was reported by a Physician from JAPAN on Jan 29, 2008. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, delirium, disease progression, enterocolitis bacterial, escherichia infection, hydrocephalus
, immune system disorder, platelet count decreased. Temodal dosage: unknown. During the same period patient was treated with BETAMETHASONE, PHENOBAL. Patient was hospitalized. Patient died on 12/02/2006.Temodal Side Effects Report #5328642-X
Temodal side effect was reported by a Physician from JAPAN on May 07, 2007. Female patient, 70 years of age, weighting 92.59 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, cytomegalovirus infection
, disseminated intravascular coagulation, hepatic function abnormal, interstitial lung disease, platelet count decreased, respiratory failure, sepsis . Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with FERON, BENAMBAX, PREDNISOLONE, NEO MINOPHAGEN C, LEBENIN, TANNALBIN, EXCEGRAN, VANCOMYCIN HYDROCHLORIDE. Patient died on 03/28/2007.Temodal Side Effects Report #5458130-1
Temodal side effect was reported by a Physician from JAPAN on Sept 11, 2007. Male patient, 66 years of age, weighting 114.6 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, glioblastoma multiforme, neoplasm progression, oral intake reduced, platelet count decreased, pneumonia aspiration. Temodal dosage: ; PO : 200 MG/M2; QD; PO : 200 MG/M2; QD; PO : 200 MG/M2; QD; PO : 200 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, FAMOTIDINE, HYDANTOL, SERMION. Patient recovered.
Temodal Side Effects Report #5989601-7
Temodal side effect was reported by a Physician from GREECE on Nov 27, 2008. Female patient, 66 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: pituitary-dependent cushing's syndrome, platelet count decreased. Temodal dosage: 140 MG;QD;PO. During the same period patient was treated with OMEPRAZOLE, KEPPRA, DEPAKENE, DEXAMETHASONE. Patient recovered.
Temodal Side Effects Report #5361145-5
Temodal side effect was reported by a Physician from JAPAN on June 08, 2007. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure, disease progression, gastrointestinal haemorrhage, glioblastoma, platelet count decreased, pneumocystis jiroveci pneumonia. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with VALPROATE, TAGAMET, BETAMETHASONE, NASEA, DOGMATYL, MAALOX FAST BLOCKER, MAGLAX, PURSENNID. Patient died on 05/09/2007.
Temodal Side Effects Report #5400018-6
Temodal side effect was reported by a Physician from CANADA on July 11, 2007. Female patient, 65 years of age, weighting 160.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: asthenia, fatigue, lethargy, malaise, platelet count decreased. Temodal dosage: 130 MG; QD; PO. During the same period patient was treated with ALTACE, DECADRON, INSULIN, KYTRIL, SYNTHROID. Patient recovered.
Temodal Side Effects Report #5201845-0
Temodal side effect was reported by a Physician from JAPAN on Dec 28, 2006. Female patient, 63 years of age, weighting 130.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: contusion, fall
, fatigue, head injury, nausea , platelet count decreased, septic shock, white blood cell count decreased. Temodal dosage: 100 MG; QD; PO. During the same period patient was treated with NAUZELIN, PRIMPERAN, NASEA. Patient died on 12/17/2006.Temodal Side Effects Report #5317860-2
Temodal side effect was reported by a Physician from JAPAN on Apr 26, 2007. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, lung disorder, meningioma malignant, platelet count decreased, pneumonia
, respiratory failure, shock, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, EXCEGRAN, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.Temodal Side Effects Report #5429903-6
Temodal side effect was reported by a Physician from JAPAN on Aug 21, 2007. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, lung disorder, platelet count decreased, pneumonia
, respiratory failure, shock, white blood cell count decreased. Temodal dosage: 250 MG; QD; PO, 250 MG; QD; PO, 150 MG/M2; QD; PO. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, EXCEGRAN, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.Temodal Side Effects Report #5568677-5
Temodal side effect was reported by a Physician from JAPAN on Mar 30, 2007. Male patient, 63 years of age, weighting 121.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood albumin decreased, liver disorder, nausea
, platelet count decreased, sepsis . Temodal dosage: 150 MG/M2;QD;PO. During the same period patient was treated with RINDERON, ZANTAC, TAGAMET, AMLODIN. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5613348-X
Temodal side effect was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: brain neoplasm, disease progression, loss of consciousness, lung disorder, meningioma malignant, platelet count decreased, pneumonia
. Temodal dosage: 250 MG; QD; PO; 150 MG/M2;QD;PO. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, ZONISAMIDE, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.Temodal Side Effects Report #5792660-8
Temodal side effect was reported by a Physician from JAPAN on June 20, 2008. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: hypoalbuminaemia, loss of consciousness, lung disorder, malignant neoplasm progression, platelet count decreased, pneumonia
, respiratory failure. Temodal dosage: 250 MG; QD; PO; 150 MG/M2; QD; PO. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, EXCEGRAN, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.Temodal Side Effects Report #5297402-0
Temodal side effect was reported by a Physician from JAPAN on Mar 29, 2007. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: depressed level of consciousness, platelet count decreased, tumour haemorrhage. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with NIMUSTINE HYDROCHLORIDE, PROCARBAZINE, SELENICA, TAKEPRON OD, PURSENNID. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5415381-X
Temodal side effect was reported by a Physician from JAPAN on Aug 08, 2007. Male patient, 60 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, platelet count decreased, pneumonia aspiration, sepsis
, vomiting. Temodal dosage: 150 MG/M2; QD;PO; 100 MG/M2;QD;PO; 150 MG/M2;QD;PO; 150 MG/M2;QD;PO. During the same period patient was treated with EXCEGRAN, SELENICA, FAMOTIDINE, MYSTAN. Patient recovered.Temodal Side Effects Report #5420738-7
Temodal side effect was reported by a Physician from JAPAN on Aug 09, 2007. Female patient, 60 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, platelet count decreased, tumour haemorrhage. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with NIMUSTINE HYDROCHLORIDE, PROCARBAZINE, SELENICA, TAKEPRON OD, PURSENNID. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5776555-1
Temodal side effect was reported by a Physician from JAPAN on June 11, 2008. Male patient, 60 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, disease progression, disseminated intravascular coagulation, platelet count decreased, pneumonia aspiration, sepsis
, vomiting, white blood cell count decreased. Temodal dosage: 150 MG/M2;QD;PO; 100 MG/M2;QD;PO. During the same period patient was treated with EXCEGRAN, SELENICA, FAMOTIDINE, MYSTAN. Patient died on 05/14/2008.Temodal Side Effects Report #5808035-9
Temodal side effect was reported by a Health Professional from UNITED KINGDOM on July 02, 2008. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, pulmonary embolism
, stevens-johnson syndrome. Temodal dosage: unknown. During the same period patient was treated with LAMICTAL. Patient died on 06/28/2008.Temodal Side Effects Report #5824184-3
Temodal side effect was reported by a Consumer or non-health professional from IRELAND on July 16, 2008. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, pulmonary embolism
, stevens-johnson syndrome. Temodal dosage: unknown. During the same period patient was treated with LAMICTAL. Patient died on 06/28/2008.Temodal Side Effects Report #5742367-8
Temodal side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: dyspnoea, hemiplegia, mobility decreased, neoplasm progression, neoplasm recurrence, neutrophil count decreased, platelet count decreased, venous thrombosis, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO; 150 MG/M2; QD; PO; 200 MG/M2; QD; PO. Patient was hospitalized and became disabled. Patient recovered.
Temodal Side Effects Report #5917630-8
Temodal side effect was reported by a Physician from JAPAN on Oct 06, 2008. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: cough, dyspnoea, hemiplegia, mobility decreased, neoplasm progression, neoplasm recurrence, neutrophil count decreased, platelet count decreased, venous thrombosis. Temodal dosage: 75 MG/M2; QD; PO, 150 MG/M2; QD; PO, 200 MG/M2; QD; PO. Patient was hospitalized and became disabled. Patient died on 01/28/2008.
Temodal Side Effects Report #6121918-8
Temodal side effect was reported by a Physician from JAPAN on Mar 06, 2009. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: aphasia
, dyspnoea, hemiplegia, neoplasm progression, neoplasm recurrence, neutrophil count decreased, platelet count decreased, venous thrombosis, white blood cell count decreased. Temodal dosage: unknown. Patient was hospitalized and became disabled. Patient died on 01/28/2008.Temodal Side Effects Report #5352141-2
Temodal side effect was reported by a Physician from ISRAEL on May 30, 2007. Male patient, 57 years of age, weighting 189.6 lb, was diagnosed with glioblastoma multiforme, brain oedema and was treated with Temodal. After drug was administered, patient experienced the following side effects: depressed level of consciousness, hypotension, platelet count decreased, pyrexia, streptococcal sepsis. Temodal dosage: 160 MG;QD;PO. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5354550-4
Temodal side effect was reported by a Physician from ISRAEL on May 31, 2007. Male patient, 57 years of age, weighting 189.6 lb, was diagnosed with glioblastoma multiforme, brain oedema and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, septic shock, streptococcal sepsis. Temodal dosage: 160 MG;QD;PO. During the same period patient was treated with DEXAMETHASONE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5504578-6
Temodal side effect was reported by a Physician from JAPAN on Oct 26, 2007. Female patient, 57 years of age, weighting 127.9 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, subdural haematoma. Temodal dosage: 200 MG/M2; QD; PO. During the same period patient was treated with VALPROATE, NASEA. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5728599-3
Temodal side effect was reported by a Physician from CANADA on Apr 22, 2008. Male patient, 57 years of age, weighting 233.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: deep vein thrombosis
, platelet count decreased. Temodal dosage: PO; 150 MG/M2; QD; PO. Patient recovered.Temodal Side Effects Report #5196360-7
Temodal side effect was reported by a Physician from JAPAN on Dec 15, 2006. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, epilepsy
, gastric ulcer, gastritis and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZONEGRAN, FAMOTIDINE, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5804112-7
Temodal side effect was reported by a Physician from JAPAN on July 01, 2008. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, epilepsy
, gastric ulcer, gastritis and was treated with Temodal. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, platelet count decreased, refusal of treatment by patient, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZONISAMIDE, FAMOTIDINE, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5931896-X
Temodal side effect was reported by a Consumer or non-health professional from JAPAN on Oct 17, 2008. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, epilepsy
, gastric ulcer, gastritis and was treated with Temodal. After drug was administered, patient experienced the following side effects: lymphocyte count decreased, pain , platelet count decreased, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZONISAMIDE, FAMOTIDINE, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5328648-0
Temodal side effect was reported by a Physician from JAPAN on May 08, 2007. Male patient, 52 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, c-reactive protein increased, haemoglobin decreased, platelet count decreased, pneumonia bacterial. Temodal dosage: unknown. During the same period patient was treated with AMOXAN, ISALON, MYSTAN, DEPAKENE, ALEVIATIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5343549-X
Temodal side effect was reported by a Physician from JAPAN on May 29, 2007. Male patient, 52 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, c-reactive protein increased, disease recurrence, haemoglobin decreased, platelet count decreased, pneumonia bacterial, post procedural infection, wound infection. Temodal dosage: unknown. During the same period patient was treated with AMOXAN, ISALON, MYSTAN, DEPAKENE, ALEVIATIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5197809-6
Temodal side effect was reported by a Physician from JAPAN on Dec 18, 2006. Male patient, 52 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, haemoglobin decreased, infection
, platelet count decreased, pneumonia bacterial, postoperative infection. Temodal dosage: 150 MG/M2, QD; PO, 200 MG/M2, QD; PO, 150 MG/M2; QD; PO. During the same period patient was treated with AMOXAN, ISALON, MYSTAN, DEPAKENE, ALEVIATIN. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5477385-0
Temodal side effect was reported by a Physician from JAPAN on Sept 25, 2007. Male patient, 52 years of age, weighting 143.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, c-reactive protein increased, platelet count decreased, pneumonia bacterial, post procedural infection. Temodal dosage: 150 MG/M2;QD;PO; 200 MG/M2;QD;PO; 150 MG/M2;QD;PO. During the same period patient was treated with AMOXAN, ISALON, MYSTAN, DEPAKENE, PHENYTOIN CAP, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5533795-4
Temodal side effect was reported by a Physician from JAPAN on Nov 26, 2007. Male patient, 33 years of age, weighting 132.3 lb, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, gastric cancer, neoplasm progression, platelet count decreased. Temodal dosage: 220 MG/M2;QD;PO; 340 MG/M2;QD;PO. During the same period patient was treated with BAKTAR. Patient died on 08/17/2007.
Temodal Side Effects Report #5701433-3
Temodal side effect was reported by a Physician from JAPAN on Apr 03, 2008. Male patient, 33 years of age, weighting 132.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, gastric cancer, glioblastoma multiforme, hepatic function abnormal, neutrophil count decreased, platelet count decreased. Temodal dosage: 220 MG/M2; QD; PO, 340 MG/M2; QD; PO, 340 MG/M2; QD; PO, 340 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, ZOFRAN ZYDIS. Patient was hospitalized. Patient died on 08/17/2007.
Temodal Side Effects Report #5343553-1
Temodal side effect was reported by a Physician from JAPAN on May 24, 2007. Female patient, 32 years of age, weighting 127.9 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: dehydration, enteritis infectious, platelet count decreased. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, GASTER D, MAGNESIUM OXIDE, MAGNESIUM OXIDE. Patient recovered.
Temodal Side Effects Report #5563300-8
Temodal side effect was reported by a Physician from JAPAN on Dec 04, 2007. Female patient, 32 years of age, weighting 127.9 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: candidiasis, dehydration, diarrhoea, enteritis infectious, enterobacter infection, enterococcal infection, platelet count decreased. Temodal dosage: 75 MG/M2;QD;PO, 75 MG/M2;QD; PO, 150 MG/M2,QD;PO, 200 MG/M2,QD. PO, 200 MG/M2,QD;PO. During the same period patient was treated with DEPAKENE, GASTER D, MAGNESIUM OXIDE, MAGNESIUM OXIDE. Patient recovered.
Temodal Side Effects Report #5740230-X
Temodal side effect was reported by a Physician from JAPAN on May 08, 2008. Male patient, 30 years of age, weighting 152.1 lb, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, dysphagia, gait disturbance, malignant neoplasm progression, platelet count decreased, pneumonia
, pulmonary embolism . Temodal dosage: 150 MG/M2; QD; PO; 200 MG/M2; QD; PO. During the same period patient was treated with ZANTAC, RINDERON, MAGMITT. Patient was hospitalized. Patient died on 02/06/2007.Temodal Side Effects Report #5883232-5
Temodal side effect was reported by a Physician from JAPAN on Sept 03, 2008. Male patient, 30 years of age, weighting 152.1 lb, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, dysphagia, gait disturbance, glioblastoma multiforme, malignant neoplasm progression, platelet count decreased, pneumonia
, pulmonary embolism . Temodal dosage: 150 MG/M2;QD;PO 200 MG/M2;QD;PO 200 MG/M2;QD;PO. During the same period patient was treated with ZANTAC, BETAMETHASONE. Patient was hospitalized and became disabled. Patient died on 02/06/2007.Temodal Side Effects Report #6099542-5
Temodal side effect was reported by a Physician from JAPAN on Feb 24, 2009. Male patient was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, hepatic function abnormal, platelet count decreased. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with INTERFERON. Patient was hospitalized. Patient died on 06/01/2008.
Temodal Side Effects Report #4614209-5
Temodal side effect was reported by a Health Professional from on Mar 07, 2005. Female patient was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: neutropenia, platelet count decreased. Temodal dosage: 70 MG ORAL. Patient died.
Temodal Side Effects Report #5055311-6
Temodal side effect was reported by a Physician from GERMANY on July 07, 2006. Male patient, 71 years of age, weighting 174.2 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumonia
, pulmonary embolism . Temodal dosage: 205 MG QD ORAL. During the same period patient was treated with CONCOR, IMODIUM, OMNIFLORA, ALBUMIN, CLEXANE, PANTOPRAZOLE, DEXAMETHASONE. Patient was hospitalized. Patient died on 07/05/2006.Temodal Side Effects Report #5858444-7
Temodal side effect was reported by a Physician from GERMANY on Aug 18, 2008. Male patient, 71 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, platelet count decreased. Temodal dosage: 150 MG QD PO. Patient died on 08/17/2008.
Temodal Side Effects Report #5046600-X
Temodal side effect was reported by a Physician from GERMANY on June 21, 2006. Male patient, 71 years of age, weighting 174.2 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumonia
. Temodal dosage: 205 MG QD ORAL. During the same period patient was treated with CONCOR, IMODIUM, OMNIFLORA, ALBUMIN, CLEXANE, PANTOPRAZOLE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5225202-6
Temodal side effect was reported by a Physician from JAPAN on Jan 24, 2007. Female patient, 65 years of age, weighting 114.6 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood beta-d-glucan increased, depressed level of consciousness, no therapeutic response, platelet count decreased, pneumocystis jiroveci pneumonia, respiratory failure, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, DOGMATYL, ZYLORIC, TRANSAMIN, BLOPRESS, COMELIAN. Patient was hospitalized. Patient died on 11/08/2006.
Temodal Side Effects Report #5162030-4
Temodal side effect was reported by a Physician from JAPAN on Nov 16, 2006. Female patient, 65 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, platelet count decreased, pneumocystis jiroveci pneumonia, respiratory disorder. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, DOGMATYL, ALLOPURINOL, TRANSAMIN, BLOPRESS, COMELIAN. Patient was hospitalized. Patient died on 11/08/2006.
Temodal Side Effects Report #5162030-4
Temodal side effect was reported by a Physician from JAPAN on Nov 16, 2006. Female patient, 65 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, platelet count decreased, pneumocystis jiroveci pneumonia, respiratory disorder. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, DOGMATYL, ALLOPURINOL, TRANSAMIN, BLOPRESS, COMELIAN. Patient was hospitalized. Patient died on 11/08/2006.
Temodal Side Effects Report #5167440-7
Temodal side effect was reported by a Physician from JAPAN on Nov 22, 2006. Female patient, 65 years of age, weighting 114.6 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, hepatic function abnormal, leukopenia, platelet count decreased, pneumocystis jiroveci pneumonia, pyrexia, respiratory disorder, respiratory failure. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, DOGMATYL, ALLOPURINOL, TRANSAMIN, BLOPRESS, COMELIAN. Patient was hospitalized. Patient died on 11/08/2006.
Temodal Side Effects Report #5199805-1
Temodal side effect was reported by a Physician from JAPAN on Dec 26, 2006. Female patient, 65 years of age, weighting 114.6 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood beta-d-glucan increased, depressed level of consciousness, leukopenia, no therapeutic response, platelet count decreased, pneumocystis jiroveci pneumonia, respiratory failure. Temodal dosage: 150 + 200 MG/M2;QD; PO -SEE IMAGE. During the same period patient was treated with DEPAKENE, DOGMATYL, ZYLORIC, TRANSAMIN, BLOPRESS, COMELIAN. Patient was hospitalized. Patient died on 11/08/2006.
Temodal Side Effects Report #5378518-7
Temodal side effect was reported by a Physician from JAPAN on June 29, 2007. Female patient, 65 years of age, weighting 114.6 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, depressed level of consciousness, leukopenia, platelet count decreased, pneumocystis jiroveci pneumonia, respiratory failure. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, DOGMATYL, ALLOPURINOL, TRANSAMIN, BLOPRESS, COMELIAN. Patient was hospitalized. Patient died on 11/08/2006.
Temodal Side Effects Report #5507376-2
Temodal side effect was reported by a Physician from UNITED KINGDOM on Oct 25, 2007. Male patient, 58 years of age, weighting 215.2 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: fall
, lung consolidation, musculoskeletal pain, neoplasm progression, platelet count decreased, pleural effusion, pulmonary embolism . Temodal dosage: 170 MG;QD;PO. During the same period patient was treated with AUGMENTIN, DEXAMETHASONE, PHENYTOIN, CODEINE SUL, PARACETAMOL, METOCLOPRAMIDE, MORPHINE, OROMORPH. Patient was hospitalized and became disabled. Patient recovered.Temodal Side Effects Report #5167460-2
Temodal side effect was reported by a Physician from JAPAN on Nov 16, 2006. Male patient, 52 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: haemoglobin decreased, platelet count decreased, pneumonia bacterial. Temodal dosage: 75 + 200 MG/M2/ QD/PO - SEE IMAGE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #4733579-0
Temodal side effect was reported by a Physician from FRANCE on July 22, 2005. Male patient, 51 years of age, weighting 121.3 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: febrile bone marrow aplasia, lymphopenia, neutropenia, platelet count decreased, pyrexia. Temodal dosage: 330 MG QD. During the same period patient was treated with OMEPRAZOLE, NEURONTIN. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5129887-4
Temodal side effect was reported by a Consumer or non-health professional from AUSTRIA on Sept 13, 2006. Male patient, weighting 178.6 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow toxicity, c-reactive protein increased, haemoglobin decreased, leukopenia, platelet count decreased, pulmonary embolism
, pyrexia. Temodal dosage: 270 MG; QD; PO. Patient recovered.Temodal Side Effects Report #5818306-8
Temodal side effect was reported by a Consumer or non-health professional from GERMANY on July 08, 2008. Male patient, weighting 176.4 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: overdose, platelet count decreased. Temodal dosage: 380 MG; QD; PO. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5818391-3
Temodal side effect was reported by a Physician from TURKEY on July 11, 2008. Female patient was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: abdominal pain
, haematocrit decreased, haemoglobin decreased, platelet count decreased, red blood cell count decreased, skin lesion. Temodal dosage: unknown. During the same period patient was treated with CORTISONE. Patient died.Temodal Side Effects Report #6058382-3
Temodal side effect was reported by a Health Professional from SWEDEN on Jan 22, 2009. Male patient was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: fall
, multi-organ failure, oxygen saturation decreased, platelet count decreased, pulmonary sepsis. Temodal dosage: 140 MG; QD;. During the same period patient was treated with RANITIDINE, TROMBYL, HERMOLEPSIN RETARD, BETAPRED. Patient was hospitalized. Patient died on 12/27/2008.Temodal Side Effects Report #5186501-X
Temodal side effect was reported by a Physician from JAPAN on Dec 07, 2006. Female patient, 56 years of age, weighting 110.2 lb, was diagnosed with epilepsy
, prophylaxis and was treated with Temodal. After drug was administered, patient experienced the following side effects: platelet count decreased, refusal of treatment by patient, stevens-johnson syndrome, white blood cell count decreased. Temodal dosage: 200 MG; PO. During the same period patient was treated with ZONEGRAN, ISOBIDE, DECADRON, ZOFRAN, TOUGHMAC E, GASTER D. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5521656-6
Temodal side effect was reported by a Physician from JAPAN on Nov 08, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with ependymoma malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hydronephrosis, liver function test abnormal, platelet count decreased, pyelonephritis, urinary tract infection
, white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with PREDONINE, ONEALFA, GLAKAY, FOSAMAC, TAKEPRON OD, FASTIC. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5574105-6
Temodal side effect was reported by a Physician from JAPAN on Dec 18, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with ependymoma malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hydronephrosis, platelet count decreased, pyelonephritis, pyrexia, urinary tract infection
, white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with PREDONINE, ONEALFA, GLAKAY, FOSAMAC, TAKEPRON OD, FASTIC. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5614235-3
Temodal side effect was reported by a Physician from JAPAN on Jan 25, 2008. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with ependymoma malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: condition aggravated, hepatic function abnormal, hydronephrosis, neurogenic bladder, platelet count decreased, pyelonephritis, urinary retention, urinary tract infection
, white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with PREDONINE, ONEALFA, GLAKAY, ALENDRONATE, TAKEPRON OD, FASTIC. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5574105-6
Temodal side effect was reported by a Physician from JAPAN on Dec 18, 2007. Female patient, 71 years of age, weighting 114.6 lb, was diagnosed with ependymoma malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: hepatic function abnormal, hydronephrosis, platelet count decreased, pyelonephritis, urinary tract infection
, white blood cell count decreased. Temodal dosage: 120 MG; QD; PO. During the same period patient was treated with PREDONINE, ONEALFA, GLAKAY, FOSAMAC, TAKEPRON OD, FASTIC. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5261487-8
Temodal side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, child 6 years of age, weighting 35.27 lb, was diagnosed with brain neoplasm and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood urea increased, brain neoplasm, disease progression, hypernatraemia, platelet count decreased, pneumonia bacterial, tumour necrosis, white blood cell count decreased. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with VEPESID, BAKTAR, LASTET S, NASEA, PRIMPERAN, DECADRON, MANNITOL, LEPETAN. Patient died on 10/26/2006.
Temodal Side Effects Report #5483215-3
Temodal side effect was reported by a Physician from JAPAN on Oct 03, 2007. Male patient, child 6 years of age, weighting 35.27 lb, was diagnosed with brain neoplasm and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood urea increased, bone marrow failure, hypernatraemia, infection
, lymphocyte count decreased, neoplasm progression, neutrophil count decreased, platelet count decreased, pneumonia bacterial. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with VEPESID, BAKTAR, LASTET S, NASEA, PRIMPERAN, DECADRON, MANNITOL, BUPRENORPHINE. Patient died on 10/26/2006.Temodal Side Effects Report #5757741-3
Temodal side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, 52 years of age, weighting 94.80 lb, was diagnosed with astrocytoma, neoplasm recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: cerebellar ataxia, insomnia, neoplasm progression, neoplasm recurrence, neutrophil count decreased, platelet count decreased, restlessness, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2; QD; PO. Patient was hospitalized. Patient died on 01/07/2008.
Temodal Side Effects Report #5859214-6
Temodal side effect was reported by a Health Professional from CANADA on Aug 20, 2008. Female patient, 30 years of age, was diagnosed with astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: contusion, convulsion, gingival bleeding, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temodal dosage: 350 MG/M2; QD; PO. Patient was hospitalized. Patient died on 08/10/2008.
Temodal Side Effects Report #5445962-9
Temodal side effect was reported by a Physician from JAPAN on Aug 30, 2007. Female patient, 74 years of age, weighting 94.80 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood sodium increased, cardiac failure acute, dyspnoea, platelet count decreased, shock. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with GLYCEOL, KYTRIL, EXCEGRAM, FAMOTIDINE, PREDONINE, EFFORTIL, MEYLON, CATABON. Patient died on 02/10/2007.
Temodal Side Effects Report #5619278-1
Temodal side effect was reported by a Physician from JAPAN on Feb 01, 2008. Female patient, 74 years of age, weighting 94.80 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood sodium increased, cardiac failure acute, platelet count decreased, protein total decreased, shock. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with GLYCEOL, KYTRIL, ZONISAMIDE, FAMOTIDINE, PREDONINE, EFFORTIL, MEYLON, CATABON. Patient died on 02/10/2007.
Temodal Side Effects Report #5683547-X
Temodal side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 74 years of age, weighting 94.80 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood pressure decreased, blood sodium increased, cardiac failure acute, dyspnoea, platelet count decreased, protein total decreased, shock. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with GLYCEOL, KYTRIL, ZONISAMIDE, FAMOTIDINE, PREDONINE, EFFORTIL, MEYLON, CATABON. Patient died on 02/10/2007.
Temodal Side Effects Report #5449481-5
Temodal side effect was reported by a Physician from JAPAN on Aug 31, 2007. Female patient, 38 years of age, weighting 110.2 lb, was diagnosed with anaplastic astrocytoma, disease recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: dehydration, headache
, muscle spasms, nausea , neoplasm progression, neutrophil count decreased, platelet count decreased, pyrexia. Temodal dosage: ; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5742497-0
Temodal side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, 38 years of age, weighting 110.2 lb, was diagnosed with anaplastic astrocytoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: convulsion, dehydration, headache
, nausea , neoplasm progression, neutrophil count decreased, platelet count decreased, pyrexia. Temodal dosage: unknown. During the same period patient was treated with PHENOBARBITAL, BAKTAR, RINDERON. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5683550-X
Temodal side effect was reported by a Physician from JAPAN on Mar 21, 2008. Male patient, 22 years of age, weighting 149.9 lb, was diagnosed with anaplastic astrocytoma, convulsion and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, brain oedema, convulsion, disease progression, hemiplegia, hepatic function abnormal, neoplasm progression, platelet count decreased. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE, TEGRETOL. Patient was hospitalized. Patient died on 06/24/2007.
Temodal Side Effects Report #4609706-2
Temodal side effect was reported by a Physician from on Mar 03, 2005. Female patient, 60 years of age, was treated with Temodal. After drug was administered, patient experienced the following side effects: aplasia, platelet count decreased. Temodal dosage: unknown. Patient recovered.
Temodal Side Effects Report #5802156-2
Temodal side effect was reported by a Physician from GREECE on June 25, 2008. Male patient, 43 years of age, was treated with Temodal. After drug was administered, patient experienced the following side effects: blood potassium increased, platelet count decreased. Temodal dosage: 140 MG; QD. During the same period patient was treated with DEPAKENE, CORTIZONE. Patient recovered.